|
|
|
Saturday, March 17, 2012 — 7:00 p.m. — Convention Centre 220-222
|
- Diagnosing Lung Carcinoma in the Era of Personalized Medicine: Clinical, Pathologic, and Molecular Aspects
|
|
Moderator:
|
Matthew A. Zarka, Mayo Clinic Arizona, Scottsdale, AZ
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| Introduction - Matthew A. Zarka, Mayo Clinic Arizona, Scottsdale, AZ |
| Clinical Approach to Cytologic and Histologic Sampling in the Patient with Lung Cancer - Robert Viggiano, Mayo Clinic Arizona, Scottsdale, AZ |
| Practical Approach to the Diagnosis and Management of Nonsmall Cell Lung Cancer Encountered in Limited Biopsy Samples (Transbronchial and Needle Core) - Kevin O. Leslie, Mayo Clinic Arizona, Scottsdale, AZ |
| AMP—CAP—IASLC Guidelines for Molecular Testing of Lung Adenocarcinoma - Neal Lindeman, Harvard Medical School, Boston, MA |
| Respiratory Tract Cytology: From Basic Morphology to Advanced Molecular Analysis - Kim R. Geisinger, Wake Forest Baptist Medical Center, Winston-Salem, NC |
|
|
|
